Insys Therapeutic (Nasdaq:INSY) is a commercial-stage specialty pharmaceutical company which mostly focuses on pain management products. It has a market cap of $673 million, and is not profitabl.. Guest Devin Shutte from The Robert Group and resident expert Paul Theron from Vestact decide whether Insys Therapeutic is hot or not.
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.